Bipolar Disorder Clinical Trials

Showing 261-280 of 340 trials

Aripiprazole in Late Life Bipolar Disorder

NCT00194038

The purpose of this research study is to analyze the effectiveness and tolerability of a new medication, aripiprazole (Abilify), in individuals age 50 years and older who have bipolar disorder (manic-depressive illness).

Bipolar Disorder

University Hospitals Cleveland Medical Center20 participantsStarted Apr 2004

TERMINATEDPHASE4

A Pilot Study Assessing EmSam in Bipolar Depression

NCT00535262

This pilot study will evaluate the efficacy of the monoamine oxidase inhibitor (MAOI)EmSam, a selegiline transdermal system (STS), in bipolar depression.

Bipolar Depression

New York State Psychiatric Institute3 participantsStarted Mar 2007

New York, New York, United States

COMPLETEDNA

Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder

NCT00763919

In this study, patients with bipolar disorder who do not take their medications as prescribed will receive specialized education and therapy treatment to determine whether the specialized treatment is effective in helping patients to take their medications consistently.

Bipolar Disorder

Case Western Reserve University43 participantsStarted Jul 2008

Cleveland, Ohio, United States

Aripiprazole in Late Life Bipolar Disorder

A Pilot Study Assessing EmSam in Bipolar Depression

Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder

Related Searches

Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder

A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder

A Novel Person-Centered Treatment Component for Substance Use Treatment

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder

Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients

Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms

Efficacy of Adjunctive Tianeptine in the Treatment of Bipolar Depression

Antimanic Drug Use in Pregnancy

Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency

Optimizing Electroconvulsive Therapy for Depression

A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence

Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder